4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Harrow, Inc. (HROW) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Nashville, United States with about 373 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, HROW reported $272M in revenue and ($5M) in net income.
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications.
Interactive charts & full statements → Open the HROW valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $272M | $200M | $130M | $89M | — |
| Gross Profit | $204M | $150M | $91M | $63M | — |
| Operating Income (EBIT) | $30M | $9M | $1M | $2M | — |
| Net Income | ($5M) | ($18M) | ($24M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $44M | $89M | $72M | $64M | $48M | — |
| Gross Profit | $27M | $71M | $54M | $48M | $32M | — |
| Operating Income (EBIT) | ($22M) | $16M | $15M | $11M | ($11M) | — |
| Net Income | ($28M) | $7M | $1M | $5M | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $400M | $389M | $312M | $157M | — |
| Total Liabilities | $347M | $320M | $242M | $130M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HROW viewer.
About TickerBase · Data methodology & sources